Auris Medical AG: 3rd Quarter Results 2015

[attheedgeofscience]

Auris Medical has just released financial information on their company for the 3rd quarter. The update includes a summary on their clinical trial programme. As always, it is well worth a read.

http://ir.aurismedical.com/phoenix.zhtml?c=253572&p=irol-newsArticle&ID=2111740

 

[swc5150]

Nice to see updated info on AM102. News regarding it kind of went dormant for a while.

 

[Nucleo]

AM-102 moving forward. Curious to see what the undisclosed target is.

 

[attheedgeofscience]

Those who wish to, can rate/share/comment on the Facebook update from Auris Medical via the embedded link below. Due to the developments related to the Autifony QUIET-1 study, as well as the acceptance of only healthy volunteers for the upcoming Otonomy OTO-311 phase-I study, not forgetting the media attack by Kerrisdale Capital on SciFluor, Auris Medical is really the only "player in the game" at the moment. Something to think about.

 

[Discovery1]

Just as a side note with regards to Auris Medical being as you say the only "player in the game" I don't agree.
I actually bought the article on SF0034 which was published in the Journal of Neuroscience, June 10, 2015, and I read it many times with a scientific perspective. And btw I encourage you to do so as well if you haven't done so.
Kerrisdale Capital has a strong opinion on the value of Scifluor as a future treatment, but they failed to understand the scientific evidence and facts proven "in vivo" with the Scifluor experiment on animal models. Of course by no means I admit these experiments guarantee any success in human trials, but Kerrisdale Capital state their arguments with a little excessive authority in my perspective. They seem to jump into quick conlusions without supporting their arguments with scientific evidence. Please read this article and you will understand my point. I simply emphasize the idea that there is no reason yet to put aside the potential of SF0034.
Food for thought.

 

[attheedgeofscience]

Of course by no means I admit these experiments guarantee any success in human trials, but Kerrisdale Capital state their arguments with a little excessive authority in my perspective. They seem to jump into quick conlusions without supporting their arguments with scientific evidence. Please read this article and you will understand my point.

Indeed I have - and more (click the link):



My guess is that you only log in to TinnitusTalk occasionally and therefore miss the continuity: